Clinical Decision Support Tool for Pre-emptive Screening of Alzheimer’s Disease
Implementing Organization
NeuroRhythm LLP, West Bengal
Project Overview
The product will be essentially an AI -based holistic risk prediction platform for early stage Alzheimer’s disease detection. Product incorporates two separate component- a) A salivary Lactoferrin (biomarker) detection kit & b) AI-based risk propensity prediction platform
Benefits
Early identification and management of the risk for Alzheimer’s in adult life will have a profound impact. Our platform aims to provide early detection and management of Alzheimer's risk, significantly reducing the disease burden and prolonging independence for individuals. By offering a cost-effective and efficient solution, it ensures rapid diagnosis and treatment, thereby revolutionizing elderly care and contributing to improved overall well-being in the aging population.
Biotechnology Industry Research Assistance Council, New Delhi
Quick Information
Thrust Areas
Medical Sciences
Focus Area
Frugal Innovation, Health
Status
Proof of Concept established
Output
Status
Proof of Concept established
TRL: Technology Readiness Level
TRL 3
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
NeuroRhythm LLP, West Bengal
Accessibility Controls